Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5,056 |
|
|||||
| News | - | ||||||
| Day High | 1.3642 | Low High |
|||||
| Day Low | 1.30 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Artelo Biosciences Inc | ARTL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0018 | -0.13% | 1.34 | 11:46:54 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.30 | 1.30 | 1.3642 | 1.3418 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 36 | 5,056 | US$ 1.32 | US$ 6,685 | - | 1.15 - 2.98 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:43:55 | 4 | US$ 1.34 | USD |
Artelo Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.21M | 3.19M | - | 0 | -9.29M | -2.91 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Artelo Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARTL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.31 | 1.39 | 1.25 | 1.30 | 8,793 | 0.03 | 2.29% |
| 1 Month | 1.51 | 1.5999 | 1.25 | 1.41 | 8,988 | -0.17 | -11.26% |
| 3 Months | 1.37 | 1.75 | 1.25 | 1.50 | 15,517 | -0.03 | -2.19% |
| 6 Months | 1.41 | 1.75 | 1.15 | 1.42 | 16,978 | -0.07 | -4.96% |
| 1 Year | 2.69 | 2.98 | 1.15 | 1.82 | 80,765 | -1.35 | -50.19% |
| 3 Years | 1.27 | 7.20 | 0.2599 | 1.04 | 966,323 | 0.07 | 5.51% |
| 5 Years | 4.95 | 7.20 | 0.2599 | 1.41 | 1,267,944 | -3.61 | -72.93% |
Artelo Biosciences Description
| Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease. |
